NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

18 hedge funds and large institutions have $9.62M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change